Two Moderna Execs Allegedly Sold Off $30 Million In Stocks Amid Charges Of Over-Hyping Of COVID-19 Vaccine Trial
In the days following Moderna's announcement of the first round trials, the company made $1.3 billion in a sale of shares to the public. At the same time, two Moderna executives sold off nearly $30 million of their combined shares.
/2020/06/GettyImages-1214819358.jpg)
/2020/06/GettyImages-1199531911.jpg)
/2020/06/GettyImages-671725908.jpg)
/2020/06/GettyImages-1205192368.jpg)
/2020/06/GettyImages-479843606.jpg)
/2020/05/Screen-Shot-2020-05-29-at-3.31.41-PM.png)
/2020/05/GettyImages-160791778.jpg)
/2020/06/rn.jpg)
/2020/05/GettyImages-1145834459.jpg)
/2020/05/GettyImages-127974488.jpg)